GB202102366D0 - Treatment - Google Patents
TreatmentInfo
- Publication number
- GB202102366D0 GB202102366D0 GBGB2102366.8A GB202102366A GB202102366D0 GB 202102366 D0 GB202102366 D0 GB 202102366D0 GB 202102366 A GB202102366 A GB 202102366A GB 202102366 D0 GB202102366 D0 GB 202102366D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2102366.8A GB202102366D0 (en) | 2021-02-19 | 2021-02-19 | Treatment |
PCT/GB2022/050438 WO2022175670A1 (en) | 2021-02-19 | 2022-02-18 | Lovastatin for use in the treatment of neuroblastoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2102366.8A GB202102366D0 (en) | 2021-02-19 | 2021-02-19 | Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202102366D0 true GB202102366D0 (en) | 2021-04-07 |
Family
ID=75339266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2102366.8A Ceased GB202102366D0 (en) | 2021-02-19 | 2021-02-19 | Treatment |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202102366D0 (en) |
WO (1) | WO2022175670A1 (en) |
-
2021
- 2021-02-19 GB GBGB2102366.8A patent/GB202102366D0/en not_active Ceased
-
2022
- 2022-02-18 WO PCT/GB2022/050438 patent/WO2022175670A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022175670A1 (en) | 2022-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202108224D0 (en) | Treatment | |
GB202016058D0 (en) | Therapeautic treatment | |
GB202003722D0 (en) | Treatment | |
GB202002711D0 (en) | Treatment | |
GB202116743D0 (en) | Treatment | |
GB202114373D0 (en) | Treatment | |
GB202109812D0 (en) | Treatment | |
GB202109815D0 (en) | Treatment | |
GB202104666D0 (en) | COVID-19 treatment | |
GB202104416D0 (en) | Treatment reginmens | |
GB202103957D0 (en) | Treatment | |
GB202103122D0 (en) | Treatment | |
GB202102488D0 (en) | Treatment | |
GB202102366D0 (en) | Treatment | |
GB202102373D0 (en) | Treatment | |
GB202102369D0 (en) | Treatment | |
GB202102410D0 (en) | Treatment | |
GB202101875D0 (en) | Treatment | |
GB202101897D0 (en) | Treatment | |
GB202101211D0 (en) | Treatment | |
GB202101213D0 (en) | Treatment | |
GB202101212D0 (en) | Treatment | |
GB202101210D0 (en) | Treatment | |
GB202100976D0 (en) | Treatment | |
GB202020157D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |